<VariationArchive VariationID="560187" VariationName="NM_004992.3(MECP2):c.[1155_1200del;987_988del]" VariationType="Haplotype" Accession="VCV000560187" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2018-09-03" MostRecentSubmission="2018-09-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Haplotype VariationID="560187" NumberOfChromosomes="1">
      <SimpleAllele AlleleID="153092" VariationID="143360">
        <GeneList>
          <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>Xq28</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
            </Location>
            <OMIM>300005</OMIM>
            <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
            <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
          </Gene>
        </GeneList>
        <Name>NM_001110792.2(MECP2):c.1191_1236del (p.Leu398fs)</Name>
        <CanonicalSPDI>NC_000023.11:154030627:GGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGCAGGGGTGGG:GGTGGG</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>Xq28</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154030628" stop="154030673" display_start="154030628" display_stop="154030673" variantLength="46" positionVCF="154030627" referenceAlleleVCF="TGGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGCAGG" alternateAlleleVCF="T" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153296079" stop="153296124" display_start="153296079" display_stop="153296124" variantLength="46" positionVCF="153296078" referenceAlleleVCF="TGGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGCAGG" alternateAlleleVCF="T" />
        </Location>
        <OtherNameList>
          <Name>NM_001110792.2(MECP2):c.1191_1236del</Name>
          <Name>p.Leu398fs</Name>
        </OtherNameList>
        <ProteinChange>L293fs</ProteinChange>
        <ProteinChange>L398fs</ProteinChange>
        <ProteinChange>L163fs</ProteinChange>
        <HGVSlist>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1155_1200delCCTGCCCCCACCTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACC">
              <Expression>NM_004992.3:c.1155_1200delCCTGCCCCCACCTCCACCTGAGCCCGAGAGCTCCGAGGACCCCACC</Expression>
            </NucleotideExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="AJ132917.1" sequenceAccession="AJ132917" sequenceVersion="1" change="c.1155_1200del46">
              <Expression>AJ132917.1:c.1155_1200del46</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153296085_153296130del" Assembly="GRCh37">
              <Expression>NC_000023.10:g.153296085_153296130del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154030634_154030679del" Assembly="GRCh38">
              <Expression>NC_000023.11:g.154030634_154030679del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_007107.3" sequenceAccession="NG_007107" sequenceVersion="3" change="g.111431_111476del">
              <Expression>NG_007107.3:g.111431_111476del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001110792.2" sequenceAccession="NM_001110792" sequenceVersion="2" change="c.1191_1236del" MANESelect="true">
              <Expression>NM_001110792.2:c.1191_1236del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001104262.1" sequenceAccession="NP_001104262" sequenceVersion="1" change="p.Leu398fs">
              <Expression>NP_001104262.1:p.Leu398fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001316337.2" sequenceAccession="NM_001316337" sequenceVersion="2" change="c.876_921del">
              <Expression>NM_001316337.2:c.876_921del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001303266.1" sequenceAccession="NP_001303266" sequenceVersion="1" change="p.Leu293fs">
              <Expression>NP_001303266.1:p.Leu293fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369391.2" sequenceAccession="NM_001369391" sequenceVersion="2" change="c.876_921del">
              <Expression>NM_001369391.2:c.876_921del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356320.1" sequenceAccession="NP_001356320" sequenceVersion="1" change="p.Leu293fs">
              <Expression>NP_001356320.1:p.Leu293fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369392.2" sequenceAccession="NM_001369392" sequenceVersion="2" change="c.876_921del">
              <Expression>NM_001369392.2:c.876_921del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356321.1" sequenceAccession="NP_001356321" sequenceVersion="1" change="p.Leu293fs">
              <Expression>NP_001356321.1:p.Leu293fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369393.2" sequenceAccession="NM_001369393" sequenceVersion="2" change="c.876_921del">
              <Expression>NM_001369393.2:c.876_921del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356322.1" sequenceAccession="NP_001356322" sequenceVersion="1" change="p.Leu293fs">
              <Expression>NP_001356322.1:p.Leu293fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369394.2" sequenceAccession="NM_001369394" sequenceVersion="2" change="c.876_921del">
              <Expression>NM_001369394.2:c.876_921del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356323.1" sequenceAccession="NP_001356323" sequenceVersion="1" change="p.Leu293fs">
              <Expression>NP_001356323.1:p.Leu293fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001386137.1" sequenceAccession="NM_001386137" sequenceVersion="1" change="c.486_531del">
              <Expression>NM_001386137.1:c.486_531del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001373066.1" sequenceAccession="NP_001373066" sequenceVersion="1" change="p.Leu163fs">
              <Expression>NP_001373066.1:p.Leu163fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001386138.1" sequenceAccession="NM_001386138" sequenceVersion="1" change="c.486_531del">
              <Expression>NM_001386138.1:c.486_531del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001373067.1" sequenceAccession="NP_001373067" sequenceVersion="1" change="p.Leu163fs">
              <Expression>NP_001373067.1:p.Leu163fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001386139.1" sequenceAccession="NM_001386139" sequenceVersion="1" change="c.486_531del">
              <Expression>NM_001386139.1:c.486_531del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001373068.1" sequenceAccession="NP_001373068" sequenceVersion="1" change="p.Leu163fs">
              <Expression>NP_001373068.1:p.Leu163fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004992.4" sequenceAccession="NM_004992" sequenceVersion="4" change="c.1155_1200del" MANEPlusClinical="true">
              <Expression>NM_004992.4:c.1155_1200del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004983.1" sequenceAccession="NP_004983" sequenceVersion="1" change="p.Leu386fs">
              <Expression>NP_004983.1:p.Leu386fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_764" sequenceAccession="LRG_764">
              <Expression>LRG_764:g.111431_111476del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_764t1" sequenceAccession="LRG_764t1">
              <Expression>LRG_764t1:c.1191_1236del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_764p1" sequenceAccession="LRG_764p1" change="p.Leu398fs">
              <Expression>LRG_764p1:p.Leu398fs</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_764t2" sequenceAccession="LRG_764t2">
              <Expression>LRG_764t2:c.1155_1200del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_764p2" sequenceAccession="LRG_764p2" change="p.Leu386fs">
              <Expression>LRG_764p2:p.Leu386fs</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1155_1200del46">
              <Expression>NM_004992.3:c.1155_1200del46</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1155_1200del">
              <Expression>NM_004992.3:c.1155_1200del</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-01-10" DateCreated="2014-08-14" MostRecentSubmission="2024-07-10" NumberOfSubmissions="6" NumberOfSubmitters="6">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic/Likely pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">16473305</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17089071</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17387578</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19914908</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">20151026</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">21982064</ID>
            </Citation>
            <Citation Type="general">
              <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/1800e0ff-7a07-4610-b124-08685add2d75</URL>
            </Citation>
            <DescriptionHistory Dated="2023-12-23">
              <Description>Pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2023-04-05">
              <Description>Pathogenic/Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2022-08-22">
              <Description>Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2022-08-07">
              <Description>Pathogenic/Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2021-05-10">
              <Description>Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2018-09-03">
              <Description>no classification for the single variant</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2018-05-29">
              <Description>Pathogenic/Likely pathogenic</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2017-04-26">
              <Description>Pathogenic</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="3220" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="2613" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Syndromic X-linked intellectual disability Lubs type</ElementValue>
                    <XRef ID="MONDO:0010283" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">MECP2 duplication syndrome</ElementValue>
                    <XRef ID="MECP2+duplication+syndrome/4540" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE</ElementValue>
                    <XRef Type="MIM" ID="300260" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">XLMR syndrome, Lubs type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Mental retardation, X-linked, Lubs type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED, WITH RECURRENT RESPIRATORY INFECTIONS</ElementValue>
                    <XRef Type="MIM" ID="300260" DB="OMIM" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Lubs X-linked mental retardation syndrome</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">MRXSL</ElementValue>
                    <XRef Type="MIM" ID="300260" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">MECP2 duplication syndrome is a severe neurodevelopmental disorder characterized by early-onset hypotonia, feeding difficulty, gastrointestinal manifestations including gastroesophageal reflux and constipation, delayed psychomotor development leading to severe intellectual disability, poor speech development, progressive spasticity, recurrent respiratory infections (in ~75% of affected individuals), and seizures (in ~50%). MECP2 duplication syndrome is 100% penetrant in males. Occasionally females have been described with a MECP2 duplication and a range of findings from mild intellectual disability to a phenotype similar to that seen in males. In addition to the core features, autistic behaviors, nonspecific neuroradiologic findings on brain MRI, mottled skin, and urogenital anomalies have been observed in several affected boys.</Attribute>
                    <XRef ID="NBK1284" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="9781" />
                    <XRef ID="9781" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301461</ID>
                    <ID Source="BookShelf">NBK1284</ID>
                  </Citation>
                  <XRef ID="1762" DB="Orphanet" />
                  <XRef ID="C1846058" DB="MedGen" />
                  <XRef ID="MONDO:0010283" DB="MONDO" />
                  <XRef Type="MIM" ID="300260" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="3215" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="3622" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Rett's disorder</ElementValue>
                    <XRef ID="Rett+syndrome/6294" DB="Genetic Alliance" />
                    <XRef ID="68618008" DB="SNOMED CT" />
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Rett syndrome</ElementValue>
                    <XRef ID="MONDO:0010726" DB="MONDO" />
                    <XRef ID="778" DB="Orphanet" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Autism, dementia, ataxia, and loss of purposeful hand use</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Preferred">RTT</ElementValue>
                    <XRef Type="MIM" ID="312750" DB="OMIM" />
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">RTS</ElementValue>
                    <XRef Type="MIM" ID="312750" DB="OMIM" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
                    <XRef ID="NBK1497" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="5696" />
                    <XRef ID="5696" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                    <XRef ID="NBK1497" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301670</ID>
                    <ID Source="BookShelf">NBK1497</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACMG, 2008">
                    <ID Source="pmc">3111012</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACMG, 2013">
                    <ID Source="PubMed">23519317</ID>
                  </Citation>
                  <XRef ID="3095" DB="Orphanet" />
                  <XRef ID="778" DB="Orphanet" />
                  <XRef ID="C0035372" DB="MedGen" />
                  <XRef ID="MONDO:0010726" DB="MONDO" />
                  <XRef Type="MIM" ID="312750" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="6528" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="1150" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Severe neonatal-onset encephalopathy with microcephaly</ElementValue>
                    <XRef ID="MONDO:0010397" DB="MONDO" />
                    <XRef ID="209370" DB="Orphanet" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Encephalopathy, neonatal severe, due to MECP2 mutations</ElementValue>
                    <XRef ID="Encephalopathy%2C+neonatal+severe%2C+due+to+MECP2+mutations/8310" DB="Genetic Alliance" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Encephalopathy, neonatal severe</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="Genetics Home Reference (GHR) links">MECP2-related severe neonatal encephalopathy</Attribute>
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="keyword">MECP2-Related Severe Neonatal Encephalopathy</Attribute>
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="17103" />
                    <XRef ID="17103" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                    <XRef ID="NBK1497" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301670</ID>
                    <ID Source="BookShelf">NBK1497</ID>
                  </Citation>
                  <XRef ID="209370" DB="Orphanet" />
                  <XRef ID="C1968556" DB="MedGen" />
                  <XRef ID="MONDO:0010397" DB="MONDO" />
                  <XRef Type="MIM" ID="300673" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="560187" DB="ClinVar" />
          <XRef ID="CA270218" DB="ClinGen" />
          <XRef Type="rs" ID="267608329" DB="dbSNP" />
        </XRefList>
      </SimpleAllele>
      <SimpleAllele AlleleID="551241" VariationID="560201">
        <GeneList>
          <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>Xq28</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
            </Location>
            <OMIM>300005</OMIM>
            <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
            <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
          </Gene>
        </GeneList>
        <Name>NM_001110792.2(MECP2):c.1023_1024del (p.Lys343fs)</Name>
        <CanonicalSPDI>NC_000023.11:154030839:CAC:C</CanonicalSPDI>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>Xq28</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154030840" stop="154030841" display_start="154030840" display_stop="154030841" variantLength="2" positionVCF="154030839" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153296291" stop="153296292" display_start="153296291" display_stop="153296292" variantLength="2" positionVCF="153296290" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
        </Location>
        <ProteinChange>K331fs</ProteinChange>
        <ProteinChange>K238fs</ProteinChange>
        <ProteinChange>K343fs</ProteinChange>
        <ProteinChange>K108fs</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153296292_153296293del" Assembly="GRCh37">
              <Expression>NC_000023.10:g.153296292_153296293del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154030841_154030842del" Assembly="GRCh38">
              <Expression>NC_000023.11:g.154030841_154030842del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_007107.3" sequenceAccession="NG_007107" sequenceVersion="3" change="g.111263_111264del">
              <Expression>NG_007107.3:g.111263_111264del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001110792.2" sequenceAccession="NM_001110792" sequenceVersion="2" change="c.1023_1024del" MANESelect="true">
              <Expression>NM_001110792.2:c.1023_1024del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001104262.1" sequenceAccession="NP_001104262" sequenceVersion="1" change="p.Lys343fs">
              <Expression>NP_001104262.1:p.Lys343fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001316337.2" sequenceAccession="NM_001316337" sequenceVersion="2" change="c.708_709del">
              <Expression>NM_001316337.2:c.708_709del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001303266.1" sequenceAccession="NP_001303266" sequenceVersion="1" change="p.Lys238fs">
              <Expression>NP_001303266.1:p.Lys238fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369391.2" sequenceAccession="NM_001369391" sequenceVersion="2" change="c.708_709del">
              <Expression>NM_001369391.2:c.708_709del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356320.1" sequenceAccession="NP_001356320" sequenceVersion="1" change="p.Lys238fs">
              <Expression>NP_001356320.1:p.Lys238fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369392.2" sequenceAccession="NM_001369392" sequenceVersion="2" change="c.708_709del">
              <Expression>NM_001369392.2:c.708_709del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356321.1" sequenceAccession="NP_001356321" sequenceVersion="1" change="p.Lys238fs">
              <Expression>NP_001356321.1:p.Lys238fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369393.2" sequenceAccession="NM_001369393" sequenceVersion="2" change="c.708_709del">
              <Expression>NM_001369393.2:c.708_709del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356322.1" sequenceAccession="NP_001356322" sequenceVersion="1" change="p.Lys238fs">
              <Expression>NP_001356322.1:p.Lys238fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001369394.2" sequenceAccession="NM_001369394" sequenceVersion="2" change="c.708_709del">
              <Expression>NM_001369394.2:c.708_709del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001356323.1" sequenceAccession="NP_001356323" sequenceVersion="1" change="p.Lys238fs">
              <Expression>NP_001356323.1:p.Lys238fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001386137.1" sequenceAccession="NM_001386137" sequenceVersion="1" change="c.318_319del">
              <Expression>NM_001386137.1:c.318_319del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001373066.1" sequenceAccession="NP_001373066" sequenceVersion="1" change="p.Lys108fs">
              <Expression>NP_001373066.1:p.Lys108fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001386138.1" sequenceAccession="NM_001386138" sequenceVersion="1" change="c.318_319del">
              <Expression>NM_001386138.1:c.318_319del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001373067.1" sequenceAccession="NP_001373067" sequenceVersion="1" change="p.Lys108fs">
              <Expression>NP_001373067.1:p.Lys108fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001386139.1" sequenceAccession="NM_001386139" sequenceVersion="1" change="c.318_319del">
              <Expression>NM_001386139.1:c.318_319del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001373068.1" sequenceAccession="NP_001373068" sequenceVersion="1" change="p.Lys108fs">
              <Expression>NP_001373068.1:p.Lys108fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_004992.4" sequenceAccession="NM_004992" sequenceVersion="4" change="c.987_988del" MANEPlusClinical="true">
              <Expression>NM_004992.4:c.987_988del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_004983.1" sequenceAccession="NP_004983" sequenceVersion="1" change="p.Lys331fs">
              <Expression>NP_004983.1:p.Lys331fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_764" sequenceAccession="LRG_764">
              <Expression>LRG_764:g.111263_111264del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_764t1" sequenceAccession="LRG_764t1">
              <Expression>LRG_764t1:c.1023_1024del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_764p1" sequenceAccession="LRG_764p1" change="p.Lys343fs">
              <Expression>LRG_764p1:p.Lys343fs</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="LRG_764t2" sequenceAccession="LRG_764t2">
              <Expression>LRG_764t2:c.987_988del</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="LRG_764p2" sequenceAccession="LRG_764p2" change="p.Lys331fs">
              <Expression>LRG_764p2:p.Lys331fs</Expression>
            </ProteinExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </GermlineClassification>
          <SomaticClinicalImpact NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </SomaticClinicalImpact>
          <OncogenicityClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </OncogenicityClassification>
        </Classifications>
        <XRefList>
          <XRef Type="rs" ID="1557136089" DB="dbSNP" />
          <XRef Type="Interpreted" ID="560187" DB="ClinVar" />
        </XRefList>
      </SimpleAllele>
      <Name>NM_004992.3(MECP2):c.[1155_1200del;987_988del]</Name>
      <VariationType>Haplotype</VariationType>
      <OtherNameList>
        <Name>p.[Lys331Glufsx9]</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_004992.3:c.[1155_1200del;987_988del]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Haplotype>
    <RCVList>
      <RCVAccession Title="NM_004992.3(MECP2):c.[1155_1200del;987_988del] AND not provided" Accession="RCV000678231" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-04-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-04-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-09-03" MostRecentSubmission="2018-09-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1568618" SubmissionDate="2015-05-13" DateLastUpdated="2018-09-03" DateCreated="2018-09-03">
        <ClinVarSubmissionID localKey="MECP2_2_3|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000804249" DateUpdated="2018-09-03" DateCreated="2018-09-03" Type="SCV" Version="1" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" OrgID="165021" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="165021" SubmitterName="Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia" Type="secondary" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-04-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Haplotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="MECP2" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_004992.3:c.987_988del</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="MECP2" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_004992.3:c.1155_1200del</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <OtherNameList>
            <Name>p.[Lys331Glufsx9]</Name>
          </OtherNameList>
        </Haplotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>variant_submission_UBE3A_MECP2_05122015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1568618" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

